Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Clinical trial NCT02830724 · RECRUITING
Trial details
- NCT number
- NCT02830724
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-06
- Primary completion
- 2029-01-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.